Cost-effectiveness of endovascular therapy for acute ischemic stroke: A systematic review of the impact of patient age
Purpose: To determine the impact of patient age on the cost-effectiveness of endovascular therapy (EVT) in addition to standard care (SC) in large-vessel-occlusion stroke for patients aged 50 to 100 years in the United States.
Materials and Methods: A decision-analytic Markov model was used to estimate direct and indirect lifetime costs and quality-adjusted life years (QALYs). Age-dependent input parameters were obtained from the literature. Deterministic and probabilistic sensitivity analysis for age at index stroke were used. The willingness-to-pay (WTP) was set to thresholds of $50 000, $100 000, and $150 000 per QALY. The study applied a U.S. setting for health care and societal perspectives. Incremental costs and effectiveness were derived from deterministic and probabilistic sensitivity analysis. Acceptability rates at different WTP thresholds were determined.
Results: EVT+SC was the dominant strategy in patients aged 50 to 79 years. The highest incremental effectiveness (2.61 QALYs) and cost-savings (health care perspective, $99 555; societal perspective, $146 385) were obtained in 50-year-old patients. In octogenarians (80–89 years), EVT+SC led to incremental QALYs at incremental costs with acceptability rates of more than 85%, more than 99%, and more than 99% at a WTP of $50 000, $100 000, and $150 000 per QALY, respectively. In nonagenarians (90–99 years), acceptability rates at a WTP of $50 000 per QALY dropped but stayed higher than 85% and higher than 95% at thresholds of $100 000 and $150 000 per QALY.
Conclusion: Using contemporary willingness-to-pay thresholds in the United States, endovascular therapy in addition to standard care reduces lifetime costs for patients up to 79 years of age and is cost-effective for patients aged 80 to 100 years.
|Persistent URL||dx.doi.org/10.1148/radiol.2018172886, hdl.handle.net/1765/109543|
Kunz, W.G, Hunink, M.G.M, Dimitriadis, K, Huber, T. (Thomas), Dorn, F. (Franziska), Meinel, F.G. (Felix G.), … Thierfelder, K.M. (2018). Cost-effectiveness of endovascular therapy for acute ischemic stroke: A systematic review of the impact of patient age. Radiology, 288(2), 518–526. doi:10.1148/radiol.2018172886